Quote:

---

Any other company would have had its SP go to-da-moon.

---

That's the source of my frustration.

There *was* fresh news in this PR and even most longs are inexplicably yawning despite further proof that Leronlimab's effectiveness is really quite earth-shattering. Now we know more patients have been jabbed and EVERY patient thus far has improved by a remarkable degree or their illness has plateaued.

Like you said, any other company would have skyrocketed. If this was a marijuana penny stock and they announced a new strain that got you an extra 5 minutes of feeling high, the PPS would have soared over $2.

Meanwhile, we have MMs battling over a penny or two.